WINDTREE THERAPEUTICS INC /DE/ Operating Lease, Payments
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Operating Lease, Payments of $436.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for the quarter ending 2019-12-31 was $230.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for the quarter ending 2019-09-30 was $227.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for the quarter ending 2019-06-30 was $241.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for the quarter ending 2019-03-31 was $253.00K.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for fiscal 2024 was $436.00K, a 22.00% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for fiscal 2023 was $559.00K, a 23.42% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for fiscal 2022 was $730.00K, a 0.54% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ operating lease, payments for fiscal 2021 was $734.00K, a 17.99% decline from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $436.00K 10-K · filed 2025-04-15 | |||
| 2023-12-31 | $559.00K 10-K · filed 2025-04-15 | |||
| 2022-12-31 | $730.00K 10-K · filed 2024-04-16 | |||
| 2021-12-31 | $734.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $895.00K 10-K · filed 2022-03-31 | |||
| 2019-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $457.00K derived: sum of 2 quarters · filed 2021-03-29 | $698.00K derived: sum of 3 quarters · filed 2021-03-29 | $951.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $227.00K 10-Q · filed 2019-11-14 | $468.00K derived: sum of 2 quarters · filed 2019-11-14 | $721.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $241.00K 10-Q · filed 2019-08-14 | $494.00K 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $253.00K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |